Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease-Reference-Cited by-同舟云学术

Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease

Published:2013-06 Issue:6 Volume:35 Page:515-523
ISSN:0387-7604
Container-title:Brain and Development
language:en
Short-container-title:Brain and Development

Author:

Suzuki Yoshiyuki

Publisher

Elsevier BV

Subject

Neurology (clinical),Developmental Neuroscience,General Medicine,Pediatrics, Perinatology and Child Health

Reference65 articles.

1. Online Mendelian Inheritance in Man (OMIM). An Online Catalog of Human Genes and Genetic Disorders. Baltimore: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University. http://www.omim.org/

2. Functions of lysosomes;De Duve;Annu Rev Physiol,1966

3. Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities;Suzuki;Perspect Med Chem,2009

4. Emerging strategies for the treatment of hereditary metabolic storage disorders;Brady;Rejuvenation Res,2006

5. β-Galactosidase-neuraminidase deficiency: restoration of β-galactosidase activity by protease inhibitors;Suzuki;J Biochem,1981

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease;Neurochemistry International;2024-09

2. Gut-Brain Axis Modulation of Metabolic Disorders: Exploring the Intertwined Neurohumoral Pathways and Therapeutic Prospects;Neurochemical Research;2024-01-20

3. Glycosphingolipids and central nervous system–related diseases;Glycosphingolipids in the Central Nervous System;2024

4. A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis;eBioMedicine;2023-06

5. Role of misfolding in rare enzymatic deficits and use of pharmacological chaperones as therapeutic approach;Frontiers in Bioscience-Landmark;2021-12-30